Page last updated: 2024-09-05

sorafenib and Radiodermatitis

sorafenib has been researched along with Radiodermatitis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brüssow, C; Guckenberger, M; Pestalozzi, B; Riesterer, O; Stieb, S; Weiler, S	1
Carrie, C; Diaz, O; Martin, E; Mazeron, R	1
Brade, AM; Chung, C; Dawson, LA; Joshua, AM	1
Auberdiac, P; Chargari, C; Magné, N; Merrouche, Y; Moncharmont, C; Spano, JP	1

Reviews

1 review(s) available for sorafenib and Radiodermatitis

Article	Year
Radiation recall dermatitis induced by sorafenib : A case study and review of the literature. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2016, Volume: 192, Issue:5 Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Radiodermatitis; Radiotherapy, Conformal; Sorafenib; Treatment Outcome	2016

Article

Year

Radiation recall dermatitis induced by sorafenib : A case study and review of the literature.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2016, Volume: 192, Issue:5

Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Radiodermatitis; Radiotherapy, Conformal; Sorafenib; Treatment Outcome

2016

Other Studies

3 other study(ies) available for sorafenib and Radiodermatitis

Article	Year
[Toxicity of radiation therapy and antiangiogenics combination: a case report]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2009, Volume: 13, Issue:3 Topics: Adenocarcinoma; Benzenesulfonates; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Radiodermatitis; Receptors, Vascular Endothelial Growth Factor; Sorafenib	2009
Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib. Anti-cancer drugs, 2010, Volume: 21, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Pyridines; Pyrroles; Radiodermatitis; Sorafenib; Sunitinib; Treatment Outcome	2010
Ultraviolet recall dermatitis reaction with sorafenib. Investigational new drugs, 2011, Volume: 29, Issue:5 Topics: Benzenesulfonates; Fatal Outcome; Humans; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Radiodermatitis; Sorafenib; Ultraviolet Rays	2011